Proposed Rule Would Nix Allowability of Congressional Investigation Costs
Client Alert | 1 min read | 02.17.16
On February 17, the Federal Register published a proposed rule that would amend the FAR to implement section 857 of the National Defense Authorization Act, making unallowable any "costs incurred by a contractor in connection with a Congressional investigation or inquiry into an issue that is the subject a proceeding resulting in a disposition" of criminal convictions, matters involving an allegation of fraud or similar misconduct, suspensions and debarments, and default terminations. The proposed rule would also expand the applicability of section 857's requirements beyond DoD to all agencies subject to the FAR, and, as written, is not clearly limited to the contractor that is actually the subject of the "proceeding or inquiry," an important detail that should be addressed in contractor and industry comments submitted over the next 60 days prior to the publication of the final rule.
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
